. Author manuscript; available in PMC: 2022 Feb 22.

Published in final edited form as: J Infect. 2020 Feb 22;80(5):536–546. doi: 10.1016/j.jinf.2020.02.009

Table 1.

Demographic, epidemiological and clinical features of the enrolled patients.

	HIV-infected patients					HIV-uninfected patients
	HIV-TB	HIV-LTBI	HIV-Low TB risk	TOTAL	P	TB	LTBI recent	LTBI remote	Low TB risk	TOTAL	P

N	32	45	90	167		170	76	34	18	298
Sex male, N (%)	24 (75.0)	39 (86.7)	74 (82.2)	137 (82.0)	0.448^*	100 (58.8)	37 (48.7)	14 (41.2)	8 (44.4)	159 (53.4)	^#0.148
Age, median (IQR)	40 (32–51)	36 (27–41)	37 (29–49)	37 (28–48)	0.185^§	37 (29–47)	39(25–54)	44 (32–56)	39 (33–46)	38 (28–49)	^§0.461
BCG-vaccinated, N (%)	23 (71.9)	35 (77.8)	19 (21.1)	77 (46.1)	<0.001^*	116 (68.2)	38 (50.0)	15 (44.1)	1 (5.5)	170 (57.0)	^#<0.001
TB diagnosis, N (%)
Microbiological confirmation	25 (78)	-	-	-	-	132 (78)	-		-	-	-
Clinical diagnosis	5(16)	-	-	-	-	38 (22)	-		-	-	-
ART, N (%)	18 (56.2)	28 (62.2)	27 (30.0)	73 (43.7)	<0.001^*	-	-		-	-	-
HIV RNA loglO copies/ml, median (IQR)	4.91	1.84	4.65	4.47	<0.001^*	-	-		-	-	-
	(3.60–5.41)	(1.59–4.29)	(3.92–5.26)	(2.22–5.18)
CD4 /mm³, Median (IQR) ⁺	124 (52–279)	626	418	417	<0.001^*	-	-		-	-	-
		(418–860)	(253 −631)	(208–646)
Origin, N (%)					<0.001^*						^*<0.001
West Europe	9 (28.1)	10 (22.2)	71 (78.9)	90 (53.9)		55 (32.3)	39 (51.3)	19 (55.9)	18 (100)	131 (44.0)
East Europe	7 (21.9)	6 (13.3)	7 (7.8)	20 (12.0)		65 (38.2)	21 (27.6)	8 (23.5)	0	94 (31.5)
Asia	1 (3.1)	2 (4.4)	0	3 (1.8)		23 (13.5)	8 (10.5)	2 (5.9)	0	33 (11.1)
Africa	8 (25.0)	7 (15.6)	4 (4.4)	19 (11.4)		14 (8.4)	5 (6.7)	5 (14.7)	0	24 (8.0)
South America	7 (21.9)	20 (44.4)	8 (8.9)	35 (21.0)		13 (7.6)	3 (3.9)	0(0)	0	16 (5.4)

TB: tuberculosis; BCG: Bacillus Calmette et Guérin; N: number; IQR: interquartile range.

^§

Kruskal Wallis.

Fisher test.

Chi Square test.

⁺

CD4 count is not available for 5 patients (1 HIV-TB, 3 HIV-LTBI, 1 HIV-Low TB risk).